[go: up one dir, main page]

DK3325080T3 - Fremgangsmåder til bedre indgivelse af aktive midler til tumorer - Google Patents

Fremgangsmåder til bedre indgivelse af aktive midler til tumorer Download PDF

Info

Publication number
DK3325080T3
DK3325080T3 DK16831139.7T DK16831139T DK3325080T3 DK 3325080 T3 DK3325080 T3 DK 3325080T3 DK 16831139 T DK16831139 T DK 16831139T DK 3325080 T3 DK3325080 T3 DK 3325080T3
Authority
DK
Denmark
Prior art keywords
tumors
procedures
active agents
better administration
administration
Prior art date
Application number
DK16831139.7T
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics Inc filed Critical Sorrento Therapeutics Inc
Application granted granted Critical
Publication of DK3325080T3 publication Critical patent/DK3325080T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DK16831139.7T 2015-07-24 2016-07-22 Fremgangsmåder til bedre indgivelse af aktive midler til tumorer DK3325080T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562196578P 2015-07-24 2015-07-24
US201562196570P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
DK3325080T3 true DK3325080T3 (da) 2021-10-04

Family

ID=57885141

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16831139.7T DK3325080T3 (da) 2015-07-24 2016-07-22 Fremgangsmåder til bedre indgivelse af aktive midler til tumorer

Country Status (15)

Country Link
US (3) US10806913B2 (da)
EP (2) EP3925599A1 (da)
JP (1) JP7082041B2 (da)
KR (1) KR20180035209A (da)
CN (2) CN107921248A (da)
AU (3) AU2016297823B2 (da)
BR (1) BR112018001292A2 (da)
CA (1) CA2991455C (da)
DK (1) DK3325080T3 (da)
ES (1) ES2891523T3 (da)
HU (1) HUE056410T2 (da)
MX (2) MX2018000166A (da)
PL (1) PL3325080T3 (da)
RU (1) RU2719943C2 (da)
WO (1) WO2017019526A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3325080T3 (pl) * 2015-07-24 2022-01-24 Sorrento Therapeutics, Inc. Sposoby lepszego dostarczania środków czynnych do guzów
HUE056424T2 (hu) * 2015-07-24 2022-02-28 Sorrento Therapeutics Inc Eljárások hatóanyagoknak a nyirokrendszerbe való bejuttatására
CN110944708B (zh) 2017-05-17 2022-12-27 麻省理工学院 组织锚定制品
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
US11659837B2 (en) 2017-07-10 2023-05-30 Basf Se Mixtures comprising an urease inhibitor (UI) and a nitrification inhibitor such as 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid (DMPSA) or 3,4-dimethyl pyrazolium glycolate (DMPG)
WO2019222570A1 (en) 2018-05-17 2019-11-21 Massachusetts Institute Of Technology Systems for electrical stimulation
EP3801464A4 (en) * 2018-05-31 2022-03-16 Sorrento Therapeutics, Inc. ANTI-LYMPHICAL SYSTEM-DIRECTED DRUG RELEASE METHODS
WO2020064082A1 (en) * 2018-09-24 2020-04-02 L'oreal Device comprising microneedles for skin-coloring
US12465736B2 (en) 2018-09-24 2025-11-11 L'oreal Device comprising microneedles for in-situ reaction of a skin
WO2021113585A1 (en) 2019-12-05 2021-06-10 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic delivery device
JP2024505198A (ja) 2021-01-22 2024-02-05 ソレント・セラピューティクス・インコーポレイテッド コロナウイルスワクチンのマイクロリットルスケールのリンパ送達のためのデバイス
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
WO2022261262A1 (en) 2021-06-09 2022-12-15 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
JP2024531337A (ja) 2021-08-18 2024-08-29 ソレント・セラピューティクス・インコーポレイテッド リンパ系を標的化する治療剤
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
MXPA02001152A (es) 2000-06-01 2002-08-20 Watson Pharmaceuticals Inc Suministro transdermico lasofoxifeno.
MXPA04002283A (es) * 2001-09-12 2004-06-29 Becton Dickinson Co Dispositivo de pluma a base de microaguja para el suministro de farmaco y metodo para utilizar el mismo.
BRPI0411428A (pt) * 2003-06-13 2006-07-25 Becton Dickinson Co distribuição intradérmica de agentes biologicamente ativos
AU2004270113A1 (en) 2003-08-26 2005-03-17 Becton, Dickinson And Company Methods for intradermal delivery of therapeutics agents
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
WO2006127962A2 (en) 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
CA2612005C (en) * 2005-06-17 2013-10-29 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
JP5860032B2 (ja) 2010-04-28 2016-02-16 キンバリー クラーク ワールドワイド インコーポレイテッド 関節リウマチ薬の送達のためのデバイス
MX346337B (es) 2010-04-28 2017-03-14 Kimberly Clark Co Dispositivo médico con nanopatrón con interacción celular mejorada.
JP5860033B2 (ja) 2010-04-28 2016-02-16 キンバリー クラーク ワールドワイド インコーポレイテッド ｓｉＲＮＡ送達用の医療デバイス
MX2012012567A (es) 2010-04-28 2012-11-21 Kimberly Clark Co Metodo para aumentar la permeabilidad de una barrera epitelial.
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
CN103987836B (zh) 2011-10-17 2018-04-10 麻省理工学院 细胞内传递
RU2630610C2 (ru) 2011-10-27 2017-09-11 Кимберли-Кларк Ворлдвайд, Инк. Трансдермальная доставка высоковязких биоактивных агентов
KR101575039B1 (ko) * 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
ES2851234T3 (es) * 2012-09-13 2021-09-03 Avraham Amir Dispositivos de suministro y métodos para aumento cutáneo
EP2897620B1 (en) 2012-09-21 2020-07-22 Intensity Therapeutics, Inc Method of treating cancer
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
KR102370538B1 (ko) 2013-02-28 2022-03-07 소렌토 쎄라퓨틱스, 인코포레이티드 경피 약물 전달 장치
US9861801B2 (en) 2013-02-28 2018-01-09 Kimberly-Clark Worldwide, Inc. Drug delivery device
AU2014270014A1 (en) 2013-05-23 2015-12-17 Kimberly-Clark Worldwide, Inc. Microneedles with improved open channel cross-sectional geometries
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
HUE056424T2 (hu) * 2015-07-24 2022-02-28 Sorrento Therapeutics Inc Eljárások hatóanyagoknak a nyirokrendszerbe való bejuttatására
PL3325080T3 (pl) * 2015-07-24 2022-01-24 Sorrento Therapeutics, Inc. Sposoby lepszego dostarczania środków czynnych do guzów

Also Published As

Publication number Publication date
CA2991455A1 (en) 2017-02-02
BR112018001292A2 (pt) 2018-09-11
MX2018000166A (es) 2018-03-26
US20180193624A1 (en) 2018-07-12
MX2022014277A (es) 2022-12-07
RU2719943C2 (ru) 2020-04-23
JP2018521755A (ja) 2018-08-09
WO2017019526A2 (en) 2017-02-02
ES2891523T3 (es) 2022-01-28
KR20180035209A (ko) 2018-04-05
PL3325080T3 (pl) 2022-01-24
AU2021200146A1 (en) 2021-03-18
AU2016297823A1 (en) 2018-02-15
EP3325080B1 (en) 2021-09-01
AU2022275397A1 (en) 2023-01-05
EP3925599A1 (en) 2021-12-22
CN107921248A (zh) 2018-04-17
EP3325080A4 (en) 2019-04-17
HUE056410T2 (hu) 2022-02-28
US10806913B2 (en) 2020-10-20
RU2018104102A3 (da) 2019-11-06
EP3325080A2 (en) 2018-05-30
RU2018104102A (ru) 2019-08-27
CN118902979A (zh) 2024-11-08
US20240238570A1 (en) 2024-07-18
AU2016297823B2 (en) 2020-10-22
US20210052871A1 (en) 2021-02-25
AU2021200146B2 (en) 2022-08-25
CA2991455C (en) 2023-10-10
JP7082041B2 (ja) 2022-06-07

Similar Documents

Publication Publication Date Title
IL281863A (en) Pharmaceutical compositions comprising meloxicam
DK3325080T3 (da) Fremgangsmåder til bedre indgivelse af aktive midler til tumorer
IL282304A (en) Topical pharmaceutical compositions
DK3797742T3 (da) Indretning til suprakoroidal indgivelse af terapeutisk middel
DK3722274T3 (da) 2-perfluorbutylpentan til oftalmisk indgivelse
DK3139986T3 (da) System til administration af terapeutisk gas
DK3350157T3 (da) Forbindelser og sammensætninger til intracellulær afgivelse af terapeutiske midler
DK3302638T3 (da) Anordning til indgivelse af lægemidler
DK3439635T3 (da) Formuleringer til behandling af fast tumor
IL253719A0 (en) Pharmaceutical compositions for combination therapy
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3378482T5 (da) Formulering til administration af antitumorlægemiddel
DK3294404T3 (da) Medicinske konnektorer konfigureret til at modtage emittere af terapeutiske midler
DK3377516T3 (da) Sammensætning til behandling af cancer
DK3116491T3 (da) Farmaceutiske sammensætninger af terapeutisk aktive forbindelser
DK3310904T3 (da) System til cellulær indgivelse af målrettet aktivstof
KR102494289B9 (ko) 활성 혼합물
PT4070788T (pt) Formulações farmacêuticas
DK3204398T3 (da) Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3523274T3 (da) Formuleringer til indgivelse af eflornithin
DK3511004T3 (da) Kombineret præparat til behandling af cancer
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3325483T3 (da) Fremgangsmåder til fremstilling af cytotoksiske benzodiazepinderivater
DK3468604T3 (da) Farmaceutiske kombinationer til behandling af cancer